Neuromyelitis Optica Spectrum Disorders
·MeSH: Neuromyelitis Optica
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| Eculizumab administration | Valneva SE (VALN) |
Frequently asked questions
How many drugs are in development for Neuromyelitis Optica Spectrum Disorders?
BioSniper tracks 1 drug in development for Neuromyelitis Optica Spectrum Disorders across 1 company.
How many clinical trials target Neuromyelitis Optica Spectrum Disorders?
There are 1 clinical trial targeting Neuromyelitis Optica Spectrum Disorders tracked by BioSniper.
Deep-dive into Neuromyelitis Optica Spectrum Disorders
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis